Drug use in prison : practices, consequences and responses
Summary
Summary, OFDT, 9 p.
December 2020
What is the extent and nature of illicit drug use in prisons in France? What are the consequences and what responses are being provided? Published in December 2019, an issue of the OFDT's Théma collection gave an overview of existing work on these issues based on a twofold approach: a literature review allowing a retrospective over 20 years and a valorisation of the Monitoring Centre's latest productions on the subject.
The state of play drawn up by this publication shows that, despite the growing attention paid to these issues in France, data on drug use in prisons remains too disparate. It should soon be expanded by the prospects set out in the roadmap 2019-2022 concerning inmates and, in particular, the results of new epidemiological surveys.
Authors : Caroline Protais, Julien Morel d’Arleux, Marie Jauffret-Roustide
Download the PDF file (1,06 Mo)
Read the complete report in French
Drugs in Europe
2020 EMCDDA European Drug Report
COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?
These and other questions are explored in the 2020 European Drug Report, our annual overview of the drug situation in Europe.
Statistical Bulletin 2020
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
